C3 - complement C3 Gene

种属: Rattus norvegicus

基因 ID: 24232 | 基因类型: protein coding

关于 C3

功能概要

Enables lipid binding activity. Involved in several processes, including positive regulation of ERK1 and ERK2 cascade; response to estradiol; and response to steroid hormone. Located in extracellular space. Used to study glomerulonephritis; membranous glomerulonephritis; obesity; pneumonia; and pre-eclampsia. Biomarker of several diseases, including artery disease (multiple); cerebrovascular disease (multiple); eye disease (multiple); pneumocystosis; and sciatic neuropathy. Human ortholog(s) of this gene implicated in several diseases, including complement deficiency (multiple); macular degeneration (multiple); paroxysmal nocturnal hemoglobinuria; sickle cell anemia; and silicosis. Orthologous to human C3 (complement C3). [provided by Alliance of Genome Resources, Apr 2022]

C3 基因产物(1)

mRNA	Protein	Name
NM_016994.2	NP_058690.2	complement C3 precursor

基因本体论

分子功能
生物过程
细胞组分

分子功能 GO 注释	逻辑证据	参考文献	来源
enables lipid binding	IDA IDA: 通过直接分析推断	11305612	RGD
enables protein binding	IPI IPI: 通过物理相互作用推断	12871224	RGD

生物过程 GO 注释	逻辑证据	参考文献	来源
involved in complement activation	IDA IDA: 通过直接分析推断	20712003	RGD
involved in positive regulation of ERK1 and ERK2 cascade	IDA IDA: 通过直接分析推断	18178156	RGD
involved in positive regulation of developmental growth	IDA IDA: 通过直接分析推断	20712003	RGD
involved in response to estradiol	IEP IEP: 通过表达模式推断	12370124	RGD
involved in response to estrogen	IEP IEP: 通过表达模式推断	11846090	RGD
involved in response to glucocorticoid	IEP IEP: 通过表达模式推断	11566438	RGD
involved in response to magnesium ion	IEP IEP: 通过表达模式推断	12759143	RGD
involved in response to progesterone	IEP IEP: 通过表达模式推断	11566438	RGD
involved in response to xenobiotic stimulus	IEP IEP: 通过表达模式推断	29695418	RGD
involved in tolerance induction	IEP IEP: 通过表达模式推断	16555329	RGD

细胞组分 GO 注释	逻辑证据	参考文献	来源
located in extracellular space	IDA IDA: 通过直接分析推断	20712003	RGD

EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断

蛋白主名

其他名称

complement C3

complement component 3

相关产品

Approval

生物活性分子 (1)

目录号	产品名	作用方式	纯度	是否罕见病
HY-127105	Iptacopan	Inhibitor	99.93%	是

抗体抑制剂 (1)

目录号	产品名	作用方式	纯度	是否罕见病
HY-P99050	Sutimlimab	Inhibitor	98.81%	否

Clinical Phase

生物活性分子 (12)

目录号	产品名	作用方式	纯度	Phase
HY-14605BS	Rasagiline-13C3 mesylate racemic	Inhibitor	/	Phase 4
HY-106178	PMX-53	Antagonist	99.98%	Phase 2
HY-P1717A	AMY-101 TFA	Inhibitor	99.83%	Phase 2
HY-N9481	Lipoteichoic acid		/	Phase 2
HY-19903	ASP-9521	Inhibitor	≥98.0%	Phase 2
HY-P3204	POT-4	Inhibitor	99.64%	Phase 2
HY-P2141A	TRV-120027 TFA	Agonist	99.69%	Phase 2
HY-P3204A	POT-4 TFA	Inhibitor	/	Phase 2
HY-112842	MBQ-167	Inhibitor	99.64%	Phase 1
HY-P1717	AMY-101	Inhibitor	/	Phase 1
HY-10819	AG2034		/	Phase 1
HY-114913	Fenarimol	Inhibitor	/	Phase 1

抗体抑制剂 (2)

目录号	产品名	作用方式	纯度	Phase
HY-P990091	Riliprubart	Inhibitor	99.90%	Phase 3
HY-P990025	Empasiprubart		99.99%	Phase 3

Pre-clinical Phase

生物活性分子 (692)

Cat. No.	产品名	作用方式	纯度	是否罕见病
HY-101502A	SB290157 trifluoroacetate	Antagonist	99.87%	否
HY-12481	SAR405	Inhibitor	99.74%	否
HY-N0376	Liquiritin		99.99%	否
HY-138161	JR14a	Antagonist	99.59%	否
HY-132295	Azenosertib	Inhibitor	99.96%	否
HY-P1036	Compstatin	Inhibitor	98.84%	否
HY-Y0479S	L-Lactic acid-13C3		99.9%	否
HY-P3252A	Pegcetacoplan acetate	Inhibitor	99.74%	否
HY-P1717B	AMY-101 acetate	Inhibitor	99.93%	否
HY-P2848	Cholesterol oxidase, Microorganism		≥90.0%	否
HY-Y0479AS	L-Lactic acid-13C3 sodium (20% in water)		99.91%	否
HY-103007	TC-G-1008	Agonist	99.36%	否
HY-15978	P7C3-A20		98.79%	否
HY-128358	MR-L2	Activator	98.63%	否
HY-108568	15-Deoxy-Δ-12,14-prostaglandin J2	Agonist	≥99.0%	否
HY-N0650S	L-Serine-13C3		98.9%	否
HY-W015913S	Sodium 2-oxopropanoate-13C3	Inhibitor	99.7%	否
HY-P1345A	TLQP-21 TFA	Agonist	99.90%	否
HY-125877	PROTAC Mcl1 degrader-1	Inhibitor	98.13%	否
HY-150644	S07-2010	Inhibitor	98.35%	否
HY-15976	P7C3		99.66%	否
HY-P2141	TRV-120027	Agonist	98.11%	否
HY-112633	SMN-C3	Modulator	99.53%	否
HY-128132	C3a receptor agonist 1	Agonist	98.16%	否
HY-Y0337S	L-Cysteine-13C3,15N		99.9%	否
HY-161022A	FL118-C3-O-C-amide-C-NH2 formate		95.82%	否
HY-124573	(R)-Odafosfamide		98.52%	否
HY-138557	AKR1C3-IN-4	Inhibitor	99.77%	否
HY-107379	AKR1C3-IN-1	Inhibitor	98.06%	否
HY-126521	N3-C3-NHS ester		99.85%	否
HY-N6978	Ascr#5		≥98.0%	否
HY-B1337S4	Choline Chloride-13C3		99.69%	否
HY-133689AS	3-Nitrophenylhydrazine-13C6 hydrochloride		98.26%	否
HY-161929	GPX4 activator 2		99.23%	否
HY-133618	Pomalidomide-C3-adavosertib	Degrader	99.84%	否
HY-147090	Tazemetostat de(methylene morpholine)-O-C3-O-C-COOH	Degrader	99.06%	否
HY-B1659S5	Glycerol-13C3		99.10%	否
HY-Y0337S4	L-Cysteine-13C3		99.90%	否
HY-162266	C3TD879		99.42%	否
HY-N0650S5	L-Serine-13C3,15N		≥98.0%	否
HY-152189	S19-1035		99.77%	否
HY-117992	BR103		99.75%	否
HY-133479	Tetrazine-Ph-NHCO-C3-NHS ester		98.40%	否
HY-W004701	Br-C3-methyl ester		98.61%	否
HY-100683	A12B4C3	Inhibitor	98.0%	否
HY-107551	Hh Pathway-IN-1		99.06%	否
HY-113128S	sn-Glycerol 3-phosphate-13C3 disodium		98.7%	否
HY-130142A	Biotinyl-NH-PEG3-C3-amido-C3-COOH		99.31%	否
HY-140902A	Biotin-PEG3-C3-NH2		≥97.0%	否
HY-155035	S07-1066	Inhibitor	99.48%	否
HY-W006057AS16	Sodium 3-methyl-2-oxobutanoate-13C5		99.00%	否
HY-W008567	N-Deschlorobenzoyl indomethacin		≥95.0%	否
HY-140928	Biotin-PEG4-amino-t-Bu-DADPS-C3-alykne		≥95.0%	否
HY-163962	L18I		99.89%	否
HY-N10361	Drupanin		99.35%	否
HY-N1981S	Triolein-13C3	Inhibitor	98.00%	否
HY-P1505A	C3a (70-77) TFA		99.79%	否
HY-113248S1	3-Nitro-L-tyrosine-13C6		≥95.0%	否
HY-131185	Pomalidomide-amido-C3-COOH		99.51%	否
HY-145225	DLin-K-C3-DMA	Chemical	98.59%	否
HY-D1342	Coumberol		99.99%	否
HY-N4134	Ciwujianoside C3	Inhibitor	99.65%	否
HY-RI00407	hsa-miR-200c-3p inhibitor		94.62%	否
HY-W422359A	2-Aminopurine-O-Ph-NHCO-C3-COOH hydrochloride		95.27%	否
HY-109154	Obafistat	Inhibitor	99.92%	否
HY-103612	Thalidomide-O-amido-C3-COOH	Inducer	98.43%	否
HY-108568S	15-Deoxy-Δ-12,14-prostaglandin J2-d4	Agonist	98.10%	否
HY-145127	ETZ		/	否
HY-148142	Pomalidomide-C3-NHS ester		98.70%	否
HY-N0680S3	Thiamine-13C3 hydrochloride		99.90%	否
HY-W004640	N-Boc-C1-PEG3-C3-NH2		≥98.0%	否
HY-12481A	SAR405 R enantiomer	Control	99.94%	否
HY-103608	(S,R,S)-AHPC-(C3-PEG)2-C6-Cl		99.89%	否
HY-130711B	(S,R,S)-AHPC-C3-NH2 hydrochloride		96.38%	否
HY-152188	AKR1C3-IN-9	Inhibitor	99.77%	否
HY-158118	Lys(CO-C3-p-I-Ph)-OMe		97.19%	否
HY-40354S	Tofacitinib-13C3		99.77%	否
HY-N0229S10	L-Alanine-13C3,15N		≥98.0%	否
HY-N0322S4	Cholesterol-13C3	Agonist	98.80%	否
HY-163032	FABP4-IN-3	Inhibitor	99.64%	否
HY-B0356AS1	Ciprofloxacin-13C3,15N monohydrochloride		99.9%	否
HY-B1773AS3	Propanoic-13C3 sodium		99.45%	否
HY-P1036A	Compstatin TFA	Inhibitor	99.07%	否
HY-100196S1	Pyrroloquinoline quinone-13C3 sodium		99.29%	否
HY-128856	P7C3-OMe		98.26%	否
HY-135306	Cl-C6-PEG4-C3-COOH		99.65%	否
HY-158122	Lys(CO-C3-p-I-Ph)-O-tBu		98.14%	否
HY-159604	METTL3-IN-9	Inhibitor	95.30%	否
HY-160897	Methoxy-PEG-C3-amide-C2-Mal		99.69%	否
HY-161022S1	FL118-C3-O-C-amide-C-NH2-d5 formate		/	否
HY-B0430S	Pantothenic acid-13C3,15N hemicalcium		99.3%	否
HY-D1581	BODIPY 505/515-8-C3-COOH		99.92%	否
HY-I0400S3	N-Acetylneuraminic acid-13C-3		≥99.0%	否
HY-N0136S1	(±)-Taxifolin-13C3	Inhibitor	99.63%	否
HY-N0229S8	L-Alanine-13C3		99.90%	否
HY-N0898S	Catechin-13C3		98.06%	否
HY-R00006	hsa-let-7c-3p mimic		93.63%	否
HY-R00407	hsa-miR-200c-3p mimic		91.78%	否
HY-R00717	hsa-miR-34c-3p mimic		94.18%	否
HY-R01568	hsa-miR-518c-3p mimic		92.33%	否
HY-R01678	hsa-miR-548c-3p mimic		92.16%	否
HY-171115	Pyrone-211		99.32%	否
HY-115560A	Thalidomide-O-amido-C3-NH2 TFA	Inducer	99.58%	否
HY-131646	Thalidomide-O-amido-C3-PEG3-C1-NH2	Inducer	99.08%	否
HY-111297	BMVC4		/	否
HY-120903	DBCO-C3-Acid		99.68%	否
HY-131455A	Biotin-C1-PEG3-C3-amido-C5-Gly-Arg-Gly-N3 TFA		≥98.0%	否
HY-131800	3'-NH2-ATP		/	否
HY-131888	Pomalidomide-C3-NH2 hydrochloride		99.72%	否
HY-133584	Bis-SS-C3-NHS ester		≥98.0%	否
HY-138847A	Thalidomide-4-O-C3-NH2 hydrochloride	Inducer	/	否
HY-139683	Antiviral agent 5	Chemical	98.93%	否
HY-140808	Azido-PEG3-C3-OH		≥98.0%	否
HY-144432S	Vitamin B5-13C3,15N hemicalcium hemihydrate		99.7%	否
HY-150156	Anti-inflammatory agent 32		99.52%	否
HY-15129S	O-Phospho-L-serine-13C3,15N	Modulator	99.19%	否
HY-161022	FL118-C3-O-C-amide-C-NH2		/	否
HY-161022S	FL118-C3-O-C-amide-C-NH2-d5		/	否
HY-163940	LX1	Inhibitor	99.13%	否
HY-N0172S	Caffeic acid-13C3	Inhibitor	/	否
HY-N0230S	β-Alanine-13C3,15N		99.99%	否
HY-N0437S2	Progesterone-13C3	Agonist	99.60%	否
HY-N0610AS2	Cinnamic acid-13C3		99.91%	否
HY-N0650S3	L-Serine-13C3,15N,d3		≥99.90%	否
HY-N1428S3	Citric acid-13C3	Inhibitor	/	否
HY-N2362S1	DL-Alanine-13C-3		≥98.0%	否
HY-N6685S1	3-Acetyldeoxynivalenol-13C17		≥99.0%	否
HY-P1398	Compstatin control peptide	Control	99.97%	否
HY-P1505	C3a (70-77)		/	否
HY-P2325	Exoenzyme C3, clostridium botulinum	Inhibitor	/	否
HY-R00407A	hsa-miR-200c-3p agomir		/	否
HY-R00840	hsa-miR-376c-3p mimic		93.13%	否
HY-RI00840	hsa-miR-376c-3p inhibitor		99.33%	否
HY-W010407S	Cyanuric acid-13C3		≥98.0%	否
HY-W010421S	Ammelide-13C3		99.85%	否
HY-W013061S1	Propane-1,2,3-triyl tripalmitate-13C3		≥98.0%	否
HY-W041171S	3-Chloro-L-tyrosine-13C6		97.6%	否
HY-W683760	N-Nitrosonornicotine		99.97%	否
HY-Y1117S2	Melamine-15N3,13C3		96.08%	否
HY-113008AS	cis-Urocanic acid-13C3	Agonist	99.46%	否
HY-113294S	3-Hydroxykynurenine-13C3,15N	Inducer	98.74%	否
HY-158861	C3-K2-E14		98.5%	否
HY-160773A	DBCO-C3-amide-PEG6-NHS ester		95.20%	否
HY-B0710S	Betaine-13C3		99.86%	否
HY-R04629	hsa-miR-29c-3p mimic		98.48%	否
HY-RS21501	C3ar1 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-W077634	3-Amino-5-hydroxybenzoic acid		99.83%	否
HY-W392808	Spacer phosphoramidite C3		≥98.0%	否
HY-18085S2	Quercetin-13C3		/	否
HY-115560	Thalidomide-O-amido-C3-NH2	Inducer	/	否
HY-129974S	3,3'-Diiodo-L-thyronine-13C6		/	否
HY-130711A	(S,R,S)-AHPC-C3-NH2 TFA		/	否
HY-131876	Thalidomide-O-C3-acid	Inducer	/	否
HY-135900	Aniline-MPB-amino-C3-PBD	Inhibitor	/	否
HY-130711	(S,R,S)-AHPC-C3-NH2		/	否
HY-131186	Pomalidomide-amido-C3-piperazine-N-Boc		/	否
HY-100582S2	Ribitol-3-13C		99.70%	否
HY-105414	Esterbut-3		/	否
HY-105969	Dichloromethotrexate		/	否
HY-112251S	D-Lin-MC3-DMA-13C3		/	否
HY-113008S1	Urocanic acid-13C3		/	否
HY-113357S	m-Coumaric acid-13C3		/	否
HY-114773	N-Undecanoyl-L-homoserine lactone		/	否
HY-115902	FGFR4-IN-7		/	否
HY-116021S	Buquinolate-13C3	Inhibitor	/	否
HY-116025	APN-C3-PEG4-alkyne		/	否
HY-116084S1	Trimethylamine-N-oxide-13C3	Activator	/	否
HY-116170	SN34037		/	否
HY-121412	Lankacidin C	Inhibitor	/	否
HY-121635	FOX-7		/	否
HY-121656	AKR1C2/3-IN-2		/	否
HY-12210	(S)-BI-1001	Inhibitor	/	否
HY-124456	Unguinol	Inhibitor	/	否
HY-12542S	Dantrolene-13C3	Inhibitor	≥99.0%	否
HY-126287	JND4135		/	否
HY-128748S4	DL-Glyceraldehyde-13C3		/	否
HY-128753S4	D-Lyxose-13C-3		/	否
HY-130142	Biotinyl-NH-PEG3-C3-amido-C3-COOH (DIPEA)		/	否
HY-130585S	Estradiol undecylate-13C3		/	否
HY-130711C	(S,R,S)-AHPC-C3-NH2 dihydrochloride		/	否
HY-131184	N-Boc-piperazine-C3-COOH		/	否
HY-131190	N-Boc-SBP-0636457-O-C3-COOH		/	否
HY-131800A	3'-NH2-ATP tetrasodium		/	否
HY-131801A	3'-NH2-GTP tetrasodium		/	否
HY-131888A	Pomalidomide-C3-NH2		/	否
HY-133403A	Biotin-C1-PEG3-C3-amine TFA		/	否
HY-133585	Bis-SS-C3-sulfo-NHS ester		/	否
HY-133702	Aniline-piperazine-C3-NH-Boc		/	否
HY-134679	N-Boc-C1-PEG5-C3-NH2		/	否
HY-134692	Azido-C1-PEG3-C3-NH2		/	否
HY-134693	Azido-C1-PEG4-C3-NH2		/	否
HY-134749	Propargyl-PEG2-urea-C3-triethoxysilane		/	否
HY-135901	Py-MPB-amino-C3-PBD	Inhibitor	/	否
HY-13632S1	Exemestane-13C3	Inhibitor	/	否
HY-136457S	2-NP-AHD-13C3		/	否
HY-13653S	(+/-)-Epigallocatechin Gallate-13C3		/	否
HY-138847	Thalidomide-O-C3-NH2	Inducer	/	否
HY-138850	Thalidomide-NH-amido-C3-NH2	Inducer	/	否
HY-138850A	Thalidomide-NH-amido-C3-NH2 hydrochloride	Inducer	/	否
HY-139145S	Etbicyphat-13C3		/	否
HY-139427S	3-Methylglutaconic acid-13C3		/	否
HY-139545	Thalidomide-4-C3-NH2 hydrochloride	Inducer	/	否
HY-139721	Tenofovir-C3-O-C15-CF3 ammonium	Inhibitor	/	否
HY-139722	Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium	Inhibitor	/	否
HY-140019	Azido-PEG3-amide-C3-triethoxysilane		/	否
HY-140288	DBCO-C3-PEG4-amine		/	否
HY-140295	DBCO-C3-PEG4-NH-Boc		/	否
HY-140347	APN-C3-NH-Boc		/	否
HY-140478	Boc-NH-PEG4-C3-acid		/	否
HY-140841	APN-C3-PEG4-azide		98.56%	否
HY-140902	rel-Biotin-PEG3-C3-NH2		/	否
HY-140927	Azido-C3-UV-biotin		/	否
HY-141065	N-(azide-PEG3)-N'-(Amine-C3-Amide-PEG4)-Cy5		/	否
HY-141407	m-PEG3-amido-C3-triethoxysilane		/	否
HY-141597	Acid-C3-SSPy		/	否
HY-141651	(S,R,S)-AHPC-C3-COOH		/	否
HY-141857S	5-(4-Hydroxyphenyl)-5-phenyl-d5-hydantoin-2,4,5-13C3		/	否
HY-141893	3-Cyanovinylcarbazole phosphoramidite	Inhibitor	/	否
HY-141901S2	Dehydroepiandrosterone-13C3		/	否
HY-141907S	17β-Estradiol-13C3		98.1%	否
HY-142140S	3-epi-25-Hydroxy Vitamin D3-d6		/	否
HY-143342	LEB-03-144		/	否
HY-143400	HSP70-IN-3	Inhibitor	/	否
HY-143439	LX-039	Antagonist	/	否
HY-143687S	3-Cyano Gimeracil methyl ether-13C3		/	否
HY-144749	AKR1C3-IN-5	Inhibitor	/	否
HY-145253	Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH	Inhibitor	/	否
HY-145254	Tri(TLR4-IN-C34-PEG2-amide-PEG1)-amide-C3-COOH	Inhibitor	/	否
HY-145255	Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH	Inhibitor	/	否
HY-14605S	Rasagiline-13C3 mesylate		/	否
HY-146573	AKR1C3-IN-6	Inhibitor	/	否
HY-146574	AKR1C3-IN-7	Inhibitor	/	否
HY-146575	AKR1C3-IN-8	Inhibitor	/	否
HY-147551S	3-Iodo-L-thyronine-13C6		/	否
HY-148471A	C3-Amide-C4-NH2		/	否
HY-148608	LysoPalloT-NH-amide-C3-ph-m-O-C11	Agonist	/	否
HY-149040	Odafosfamide	Inhibitor	/	否
HY-150624	SARS-CoV-2 nsp13-IN-3	Inhibitor	/	否
HY-150646	S07-2009	Inhibitor	/	否
HY-150648	S07-2008	Inhibitor	/	否
HY-150649	S07-2005 (racemic)	Inhibitor	/	否
HY-150650	S07-2001	Inhibitor	/	否
HY-15097S	Myricetin-13C3	Inducer	/	否
HY-151997S	1,2-Dioleoyl-3-lauroyl-rac-glycerol-13C3		/	否
HY-153456	Hedgehog IN-2	Inhibitor	/	否
HY-153539	AP-C3	Inhibitor	/	否
HY-153540	AP-C4	Inhibitor	/	否
HY-15398S1	Vitamin D3-13C3	Activator	/	否
HY-155259	Pomalidomide-5-C3-NH2 hydrochloride		96.02%	否
HY-155502	AKR1C3-IN-10	Inhibitor	/	否
HY-155716	G43-C3-TEG	Inhibitor	/	否
HY-156086	TRK-IN-24	Inhibitor	/	否
HY-157510	Thalidomide-O-C3-azide	Inducer	/	否
HY-157810	AKR1C3-IN-11	Inhibitor	/	否
HY-158383	Pomalidomide-CO-C3-PEG4-C6-NH2		/	否
HY-158732	MAO-B-IN-33	Inhibitor	/	否
HY-158994S	MEGDSRGG-(Ala-13C3,15N)-GGEA-(Leu-13C6,15N)-DPESAASSLSGAS TFA		/	否
HY-15977	(S)-P7C3-OMe		/	否
HY-161131	Lenalidomide 4'-alkyl-C3-azide		/	否
HY-161468	Thalidomide-N-C3-O-C4-O-C3-OH	Inducer	/	否
HY-161653	Boc-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione		/	否
HY-161708	PROTAC FLT3/CDKs degrader-1	Degrader	/	否
HY-161832	(S,R,S)-Me-AHPC-amide-C3-alkyne		/	否
HY-161839	AKR1C2/3-IN-1	Inhibitor	/	否
HY-162714	C3N-Dbn-Trp2	Inhibitor	/	否
HY-162816	PROTAC HPK1 Degrader-3		/	否
HY-163223	(S,R,S)-AHPC-CO-CH2-piperazine-C3-piperazine-Boc		/	否
HY-163323	AKR1C3-IN-12	Inhibitor	/	否
HY-163609	PROTAC AKR1C3 degrader-1	Degrader	/	否
HY-163610	AKR1C3-IN-13	Inhibitor	/	否
HY-163678	Pomalidomide-CO-C7-NH-CO-C3-COOH		/	否
HY-163758	COOH-C3-CONH-C7-COOH		/	否
HY-163784	AKR1C3-IN-14	Inhibitor	/	否
HY-163821	HO-CONH-C3-PEG3-NH2		/	否
HY-163903	OH-C2-PEG3-NHCO-C3-COOH		/	否
HY-163904	(S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH		/	否
HY-163964	Lenalidomide-C3-PEG3-N3		/	否
HY-164085	Azide-C3-NHCO-C3-NHS ester		/	否
HY-164909	PZ-3022		/	否
HY-166939S	3,4,5,6-Tetrabromo[1,1′-biphenyl]-2,2′-diol-13C12		/	否
HY-168239	Thalidomide-piperidine-CO-piperazine-C-3-Br-Ph		/	否
HY-169401	L321-NH-C3-PEG3-C1-NH2		/	否
HY-170531	SR 142948-C3-NHMe		/	否
HY-170808	PROTAC BRD4 Degrader-28	Degrader	/	否
HY-170867	Nrf2/HO-1 activator 3		/	否
HY-170978	PROTAC CDK9 degrader-11	Degrader	/	否
HY-171544	AGS-16C3F		/	否
HY-172804	SDH-IN-26		/	否
HY-173132	AKR1Cs-IN-1	Inhibitor	/	否
HY-173453	AKR1C3-IN-15		/	否
HY-173500	MG-3C		/	否
HY-174384	MET Transcription-IN-1		/	否
HY-17461S	Cortisone-13C3	Agonist	/	否
HY-175193	N-Deshydroxyethyl Dasatinib-C3-NH2	Inhibitor	/	否
HY-176037	Boc-C3-amide-C10-amine		/	否
HY-176084	RJG-2051	Inhibitor	/	否
HY-176243	15-Deoxy-Δ12,14-Prostaglandin J2-2-glyceryl ester	Agonist	/	否
HY-19717S	DCVC-13C3,15N		/	否
HY-23506S	1-Aminohydantoin-13C3		/	否
HY-32351B	3-epi-Calcifediol		/	否
HY-34628S1	Tri-O-acetyl-D-glucall-13C-1		/	否
HY-34628S2	Tri-O-acetyl-D-glucal-13C-2		/	否
HY-79395S1	Dimethyl carbonate-13C3		/	否
HY-A0067S1	Oxybenzone-13C6		/	否
HY-A0090S	Nitrofurantoin-13C3	Inhibitor	/	否
HY-A0132S5	N-Acetyl-D-glucosamine-13C-3		/	否
HY-A0132S9	N-Acetyl-D-glucosamine-13C3,15N		/	否
HY-A0253S	Cefacetrile-13C3		/	否
HY-B0143S4	Niacin-15N,13C3		/	否
HY-B0150S1	Nicotinamide-15N,13C3	Inhibitor	/	否
HY-B0166S4	L-Ascorbic acid-13C-3		/	否
HY-B0228S3	Adenosine-3′-13C		/	否
HY-B0234S	Estrone-13C3	Agonist	98.0%	否
HY-B0388S	Probucol-13C3	Inhibitor	/	否
HY-B0389S18	D-Glucose-13C3-1		/	否
HY-B0389S9	D-Glucose-13C3-2		/	否
HY-B0412S3	Estriol-13C3	Antagonist	/	否
HY-B0495S	Lamotrigine-13C3,d3		/	否
HY-B0495S4	Lamotrigine-13C3		/	否
HY-B0526S	Flumequine-13C3	Inhibitor	/	否
HY-B0636S1	Triamcinolone acetonide-13C3		/	否
HY-B0891S1	17α-Hydroxyprogesterone-13C3	Agonist	98.9%	否
HY-B1075AS	(Rac)-Fosfomycin (benzylamine)-13C3		/	否
HY-B1331S1	Cyromazine-13C3		/	否
HY-B1449S4	Uridine-13C-3		/	否
HY-B1659S	Glycerol-13C3,d8		/	否
HY-B1732S1	DL-3-Phenylalanine-13C		/	否
HY-B1804S	Tricaprilin-13C3		/	否
HY-B1805S1	Triclocarban-13C13	Inhibitor	/	否
HY-CE00612	2'-(5''-Phosphoribosyl)-3'-dephospho-CoA		/	否
HY-CE00614	2'-(5-Triphosphoribosyl)-3'-dephospho-CoA		/	否
HY-D1056A5	Lipopolysaccharides, from E. coli K-235	Activator	/	否
HY-D1516	NerveGreen C3		/	否
HY-D1558	1,3,5,7-Tetramethyl-2,6-diiodo-C3-SE-BODIPYs		/	否
HY-D2200	Cy5.5(Me)-C3-DBCO		/	否
HY-E70152	ST6 Sialyltransferase 4		/	否
HY-N0001S	(±)-Epicatechin-13C3		/	否
HY-N0055S	Chlorogenic acid-13C3		/	否
HY-N0059S3	D-Arabinose-13C-3		/	否
HY-N0060S1	Ferulic acid-13C3	Inhibitor	98.3%	否
HY-N0086S3	N6-Methyladenosine-13C3	Inhibitor	/	否
HY-N0210S2	D-Galactose-13C-3		/	否
HY-N0229S5	L-Alanine-13C3,15N,d4		/	否
HY-N0351S	p-Coumaric acid-13C3		99.0%	否
HY-N0356S	(+/-)-Catechin Gallate-13C3	Inhibitor	/	否
HY-N0376R	Liquiritin (Standard)		/	否
HY-N0379S8	D-Mannose-13C-3		/	否
HY-N0382S	Galangin-13C3		/	否
HY-N0464S	Quinic acid-13C3	Inhibitor	/	否
HY-N0521AS	(+)-Gallocatechin-13C3		/	否
HY-N0537S5	Xylose-3-13C		/	否
HY-N0683S1	2-ambo-Vitamin E-13C3	Inhibitor	/	否
HY-N0771S6	L-Cysteine-13C3,15N,d3		/	否
HY-N10263	Palmarumycin C3		/	否
HY-N10519	Cellooctaose		/	否
HY-N10998	Chamaejasmenin A		/	否
HY-N11646	Ganorbiformin B	Inhibitor	/	否
HY-N1480S3	(-)-Fucose-13C-3		/	否
HY-N2041S4	Myristic acid-13C3		/	否
HY-N3205	Neochamaejasmin B		≥95.0%	否
HY-N8847S	α-Ionone-13C3		/	否
HY-N9332	Kalopanax saponin G		/	否
HY-NP202	C2 Protein (human)		/	否
HY-NP202A	C3 Protein (human)		/	否
HY-P1142S	GLP-2(rat) (Ala-13C3,15N)		/	否
HY-P1142S1	GLP-2(rat) (Ala-13C3,15N) TFA		/	否
HY-P1345	TLQP-21	Agonist	/	否
HY-P1398A	Compstatin control peptide TFA	Control	/	否
HY-P1640	(Trp63,Trp64)-C3a(63-77)	Agonist	/	否
HY-P5071	EcAMP3		/	否
HY-R00006A	hsa-let-7c-3p agomir		/	否
HY-R00333	hsa-miR-181c-3p mimic		/	否
HY-R00333A	hsa-miR-181c-3p agomir		/	否
HY-R00717A	hsa-miR-34c-3p agomir		/	否
HY-R00832	hsa-miR-374c-3p mimic		/	否
HY-R00832A	hsa-miR-374c-3p agomir		/	否
HY-R00840A	hsa-miR-376c-3p agomir		/	否
HY-R01112	hsa-miR-449c-3p mimic		/	否
HY-R01112A	hsa-miR-449c-3p agomir		/	否
HY-R01546	hsa-miR-513c-3p mimic		/	否
HY-R01546A	hsa-miR-513c-3p agomir		/	否
HY-R01568A	hsa-miR-518c-3p agomir		/	否
HY-R01590	hsa-miR-519c-3p mimic		/	否
HY-R01590A	hsa-miR-519c-3p agomir		/	否
HY-R01598	hsa-miR-520c-3p mimic		/	否
HY-R01598A	hsa-miR-520c-3p agomir		/	否
HY-R01678A	hsa-miR-548c-3p agomir		/	否
HY-R02506	hsa-miR-892c-3p mimic		/	否
HY-R02506A	hsa-miR-892c-3p agomir		/	否
HY-R02698	mmu-miR-181c-3p mimic		/	否
HY-R02698A	mmu-miR-181c-3p agomir		/	否
HY-R02795	mmu-miR-1970c-3p mimic		/	否
HY-R02795A	mmu-miR-1970c-3p agomir		/	否
HY-R02833	mmu-miR-216c-3p mimic		/	否
HY-R02833A	mmu-miR-216c-3p agomir		/	否
HY-R02840	mmu-miR-219c-3p mimic		/	否
HY-R02840A	mmu-miR-219c-3p agomir		/	否
HY-R02897	mmu-miR-302c-3p mimic		/	否
HY-R02897A	mmu-miR-302c-3p agomir		/	否
HY-R03043	mmu-miR-344c-3p mimic		/	否
HY-R03043A	mmu-miR-344c-3p agomir		/	否
HY-R03077	mmu-miR-34c-3p mimic		/	否
HY-R03077A	mmu-miR-34c-3p agomir		/	否
HY-R03104	mmu-miR-374c-3p mimic		/	否
HY-R03104A	mmu-miR-374c-3p agomir		/	否
HY-R03111	mmu-miR-376c-3p mimic		/	否
HY-R03111A	mmu-miR-376c-3p agomir		/	否
HY-R03148	mmu-miR-449c-3p mimic		/	否
HY-R03148A	mmu-miR-449c-3p agomir		/	否
HY-R03198	mmu-miR-467c-3p mimic		/	否
HY-R03198A	mmu-miR-467c-3p agomir		/	否
HY-R03460	mmu-miR-669c-3p mimic		/	否
HY-R03460A	mmu-miR-669c-3p agomir		/	否
HY-R04277	rno-miR-196c-3p mimic		/	否
HY-R04277A	rno-miR-196c-3p agomir		/	否
HY-R04284	rno-miR-200c-3p mimic		/	否
HY-R04284A	rno-miR-200c-3p agomir		/	否
HY-R04468	rno-miR-449c-3p mimic		/	否
HY-R04468A	rno-miR-449c-3p agomir		/	否
HY-R04484	rno-miR-466c-3p mimic		/	否
HY-R04484A	rno-miR-466c-3p agomir		/	否
HY-RI00006	hsa-let-7c-3p inhibitor		/	否
HY-RI00006A	hsa-let-7c-3p antagomir		/	否
HY-RI00333	hsa-miR-181c-3p inhibitor		/	否
HY-RI00333A	hsa-miR-181c-3p antagomir		/	否
HY-RI00407A	hsa-miR-200c-3p antagomir		/	否
HY-RI00717	hsa-miR-34c-3p inhibitor		/	否
HY-RI00717A	hsa-miR-34c-3p antagomir		/	否
HY-RI00832	hsa-miR-374c-3p inhibitor		/	否
HY-RI00832A	hsa-miR-374c-3p antagomir		/	否
HY-RI00840A	hsa-miR-376c-3p antagomir		/	否
HY-RI01112	hsa-miR-449c-3p inhibitor		/	否
HY-RI01112A	hsa-miR-449c-3p antagomir		/	否
HY-RI01546	hsa-miR-513c-3p inhibitor		/	否
HY-RI01546A	hsa-miR-513c-3p antagomir		/	否
HY-RI01568	hsa-miR-518c-3p inhibitor		/	否
HY-RI01568A	hsa-miR-518c-3p antagomir		/	否
HY-RI01590	hsa-miR-519c-3p inhibitor		/	否
HY-RI01590A	hsa-miR-519c-3p antagomir		/	否
HY-RI01598	hsa-miR-520c-3p inhibitor		/	否
HY-RI01598A	hsa-miR-520c-3p antagomir		/	否
HY-RI01678	hsa-miR-548c-3p inhibitor		/	否
HY-RI01678A	hsa-miR-548c-3p antagomir		/	否
HY-RI02506	hsa-miR-892c-3p inhibitor		/	否
HY-RI02506A	hsa-miR-892c-3p antagomir		/	否
HY-RI02698	mmu-miR-181c-3p inhibitor		/	否
HY-RI02698A	mmu-miR-181c-3p antagomir		/	否
HY-RI02795	mmu-miR-1970c-3p inhibitor		/	否
HY-RI02795A	mmu-miR-1970c-3p antagomir		/	否
HY-RI02833	mmu-miR-216c-3p inhibitor		/	否
HY-RI02833A	mmu-miR-216c-3p antagomir		/	否
HY-RI02840	mmu-miR-219c-3p inhibitor		/	否
HY-RI02840A	mmu-miR-219c-3p antagomir		/	否
HY-RI02897	mmu-miR-302c-3p inhibitor		/	否
HY-RI02897A	mmu-miR-302c-3p antagomir		/	否
HY-RI03043	mmu-miR-344c-3p inhibitor		/	否
HY-RI03043A	mmu-miR-344c-3p antagomir		/	否
HY-RI03077	mmu-miR-34c-3p inhibitor		/	否
HY-RI03077A	mmu-miR-34c-3p antagomir		/	否
HY-RI03104	mmu-miR-374c-3p inhibitor		/	否
HY-RI03104A	mmu-miR-374c-3p antagomir		/	否
HY-RI03111	mmu-miR-376c-3p inhibitor		/	否
HY-RI03111A	mmu-miR-376c-3p antagomir		/	否
HY-RI03148	mmu-miR-449c-3p inhibitor		/	否
HY-RI03148A	mmu-miR-449c-3p antagomir		/	否
HY-RI03198	mmu-miR-467c-3p inhibitor		/	否
HY-RI03198A	mmu-miR-467c-3p antagomir		/	否
HY-RI03460	mmu-miR-669c-3p inhibitor		/	否
HY-RI03460A	mmu-miR-669c-3p antagomir		/	否
HY-RI04277	rno-miR-196c-3p inhibitor		/	否
HY-RI04277A	rno-miR-196c-3p antagomir		/	否
HY-RI04284	rno-miR-200c-3p inhibitor		/	否
HY-RI04284A	rno-miR-200c-3p antagomir		/	否
HY-RI04468	rno-miR-449c-3p inhibitor		/	否
HY-RI04468A	rno-miR-449c-3p antagomir		/	否
HY-RI04484	rno-miR-466c-3p inhibitor		/	否
HY-RI04484A	rno-miR-466c-3p antagomir		/	否
HY-RS00536	AKR1C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS01743	C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS01744	C3AR1 Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS05969	H3C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS05976	H4C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS10520	PIK3C3 Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS10521	Pik3c3 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS10522	Pik3c3 Rat Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-W007376S	Indole-3-carboxaldehyde-13C		/	否
HY-W007798S	Fmoc-Cys(Trt)-OH-1,2,3-13C3,15N		/	否
HY-W007928S	1-O-Acetyl 2,3,5-tri-O-benzoyl-beta-D-ribofuranoside-13C		/	否
HY-W009204S4	Fmoc-Ala-OH-13C3,15N		/	否
HY-W010407S2	Cyanuric acid-13C3,15N3		/	否
HY-W010575S	(2R)-3-Amino-2-fluoropropanoic acid-13C3		/	否
HY-W010596S	Malonamide-13C3		/	否
HY-W011683S2	2'-Deoxyadenosine monohydrate-3′-13C		/	否
HY-W013061S4	Propane-1,2,3-triyl tripalmitate-13C3-1		/	否
HY-W015084S	β-Ionone-13C3	Inducer	/	否
HY-W015824S2	DL-Aspartic acid-3-13C		/	否
HY-W017529S	6-Chloro-1,3,5-triazine-2,4-diamine-13C3		/	否
HY-W017540S	Cyclocreatine-13C3		/	否
HY-W018386S	3-Bromo-L-tyrosine-13C6		/	否
HY-W018386S1	3-Bromo-L-tyrosine-13C9		/	否
HY-W018772S4	D-Ribose-13C-3		/	否
HY-W024692	Indomethacin methylester	Inhibitor	/	否
HY-W040047S	Pregnanediol 3-glucuronide-13C5		/	否
HY-W040240S1	(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-1		/	否
HY-W040240S2	(3S,4R,5S)-1,3,4,5,6-Pentahydroxyhexan-2-one-13C-2		/	否
HY-W096151	Chloroacetamido-C-PEG3-C3-NHBoc		/	否
HY-W099927	[C3MPr]NTf2		/	否
HY-W127393	N-Nonanoyl-L-homoserine lactone		/	否
HY-W127487	N-Octadecanoyl-L-homoserine lactone		/	否
HY-W269693S	5-(4-Hydroxyphenyl)-5-phenylimidazolidine-2,4-dione-d5,13C3		/	否
HY-W324220	11β-HSD1-IN-10		/	否
HY-W357090S	L-Idose-13C-3		/	否
HY-W584535	VH032-C3-Boc		/	否
HY-W585905	Trimethylammonium chloride-13C3		/	否
HY-W653931	rac 1,2-Bis-palmitoyl-3-chloropropanediol-13C3		/	否
HY-W653989	Desonide-13C3		/	否
HY-W654296	Octocrylene-13C3		/	否
HY-W654331	Quinolinic acid-13C3, 15N		/	否
HY-W706737	N-Deschlorobenzoyl indomethacin-d3		/	否
HY-W747332	Pyruvic aldehyde-13C3		/	否
HY-W747791	4,6-Dichloro-1,3,5-triazin-2-amine-13C3		/	否
HY-W748430	Furagin-13C3		/	否
HY-W748519	Sarcosine-13C3		/	否
HY-W749145	2-Chloro-5-thiazolecarboxylic Acid-13C3,15N		/	否
HY-W749394	4-Methyl-5-thiazoleethanol-13C3		/	否
HY-W749519	(E,E)-Farnesol-13C3		/	否
HY-W749528	3-Deoxyglucosone-13C6		/	否
HY-W749742	Isopropyltriphenylphosphonium bromide-13C3		/	否
HY-W750553	2-Ethylhexyl 2-cyanoacetate-13C3		/	否
HY-W751156	O-Phospho-L-serine-13C3		/	否
HY-W751753	Ethyl (2-cyanoacetyl)carbamate-13C3,15N		/	否
HY-W751756	6-Cyano Diclazuril-13C3,15N2		/	否
HY-W751832	5,6-Diaminopyrimidine-2,4-diol hydrochloride-13C3		/	否
HY-W751834	6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione-13C3		/	否
HY-W753497	Benzene-1,2,4-tricarboxylic acid-13C3		/	否
HY-W753983	Pyruvic acid-13C3		/	否
HY-W754236	(R)-Carnitine Hydrochloride-13C3		/	否
HY-W759219	Adrenosterone-13C3		/	否
HY-W759459	Meldrum's acid-13C3		/	否
HY-W765177	Acetyl-L-carnitine hydrochloride-13C3		/	否
HY-W766603	Thiouric Acid Sodium Salt Dihydrate-13C3		/	否
HY-W767601	(3S,6S)-3,6-Dimethyl-1,4-dioxane-2,5-dione-13C2		/	否
HY-W768226	D-Fructose-1,2,3-13C3		/	否
HY-W768527	Methyl piperidine-4-carboxylate hydrochloride-13C3		/	否
HY-W768964	a,a-Dimethyl-1H-indole-2-acetonitrile-13C315N		/	否
HY-W768990	Vinclozolin-13C3,d3		/	否
HY-W769556	Ethyl Cyano(ethoxymethylene)acetate-13C3		/	否
HY-W770279	DL-Cytarabine-13C3		/	否
HY-W770914	Stearoyl-L-carnitine chloride-13C3		/	否
HY-W776973	Glycidamide-13C3		/	否
HY-W777002	Famotidine-13C3		/	否
HY-W777084	(E)-3,4-Dimethoxycinnamic acid-13C3		/	否
HY-W777266	Cyclohexane-1,3-dione-13C3		/	否
HY-W777281	Fluocinolone acetonide-13C3		/	否
HY-W777340	Gimeracil-13C3		/	否
HY-W777351	Etravirine-13C3		/	否
HY-W777615	Ammeline Hydrochloride-13C3		/	否
HY-W777751	6-Desamino 6-chloro etravirine-13C3		/	否
HY-W777806	Pyrimido[1,2-a]purin-10(1H)-one-13C3		/	否
HY-W777836	2,2-Dibromomalonamide-13C3		/	否
HY-W777862	1-Stearoyl-rac-glycerol-13C3,d5		/	否
HY-W778057	Ethyl 3,4-Dihydroxybenzoate-13C3		/	否
HY-W778242	3,4-Dihydronaphthalen-1-one-13C6		/	否
HY-W778286	Enterolactone-13C3		/	否
HY-W778288	(±)-Enterodiol-13C3		/	否
HY-W778511	Levulinic acid-13C3		/	否
HY-W778954	2,2-Dimethyl-1,3-dioxolane-4-methanol-13C3		/	否
HY-W779236	Ethyl Propargylate-13C3		/	否
HY-Y0418S3	Dulcite-13C-3		/	否
HY-Y0504S	Trimethylammonium chloride-13c3,d9		/	否
HY-Y0659S1	1,2,3,4-Hydroquinoline-13C3,15N		/	否
HY-Y0721S	3-Bromofluorobenzene-13C6		/	否
HY-Y0921S3	(±)-1,2-Propanediol-13C3		/	否
HY-Y1117S1	Melamine-13C3		98.71%	否
HY-Y1662	D-Aminoacylase		/	否
HY-10002S	Calcitriol-13C3	Inhibitor	≥97.0%	否
HY-100840	(S)-4C3HPG		/	否
HY-100840A	(RS)-4C3HPG	Antagonist	/	否
HY-115767S	(±)-1,2-Diolein-13C3	Activator	/	否
HY-118329	S 135		/	否
HY-120157	Vif-ElonginC interaction inhibitor 1	Inhibitor	/	否
HY-122585	proMMP-9 inhibitor-3c	Inhibitor	/	否
HY-127035S1	Tristearin-13C3		/	否
HY-137225	HTS07944		/	否
HY-139227	Thalidomide 4'-oxyacetamide-C1-PEG3-C3-amine hydrochloride	Inducer	/	否
HY-141582S	Ceramide 3-d3		/	否
HY-144344S	Benzyl(2R)-3-N,N-dibenzylamino-2-fluoropropanoate-13C3		/	否
HY-149560	Thalidomide-5-O-C3-NH2 hydrochloride		99.08%	否
HY-149749	Methylthiomcresol-C3-COOH		/	否
HY-150532S	(Rac)-Vitamin B5,Calcium Salt Hydrate-13C3 15N		/	否
HY-154746S	3-HPMA Potassium Salt-3-13C3,15N		/	否
HY-154814S	Monohydroxy-3-butenyl-mercapturic acid-13C3,15N sodium		/	否
HY-156326S	(3E,5E)-Octadien-2-one-13C2		/	否
HY-156326S1	(3E,5Z)-Octadien-2-one-13C2		/	否
HY-159145	Lenalidomide-acetylene-C3-MsO		/	否
HY-161652	Thalidomide-NH-C3-O-Ph(NO2)-methylester-O-pyrrolidine-2,5-dione		/	否
HY-161656	PIP-C-3-Azaspiro[5.5]undecane-boc		/	否
HY-163267	ZNL0325		/	否
HY-163647	Lenalidomide-COCH-PEG2-azido		/	否
HY-165686	Benalaxyl metabolite M2-13C3		/	否
HY-168192	Thalidomide-NH-C4-amide-C3-Br		/	否
HY-168380	Lipid C3		/	否
HY-172223	3-Deazaguanosine	Inhibitor	/	否
HY-172296	Biotinamide-C3-PEG3-C-alkyne		/	否
HY-173103S	FYDPL(Ala-13C3,15N)GK TFA		/	否
HY-17469S	Gimeracil-13C3,15N		/	否
HY-176038	MS1262-C3-amide-C10-amine		/	否
HY-23805S	3,6-Dichloro-9H-carbazole-13C12		/	否
HY-40354S1	Tofacitinib-13C3,15N		/	否
HY-B0111RS	Drospirenone-13C3		/	否
HY-B0389S13	D-Glucose-13C-3		/	否
HY-B0399S2	L-Carnitine-13C3		/	否
HY-B0510S3	Trimethoprim-13C3	Inhibitor	/	否
HY-B0945S	Nitromide-13C6		/	否
HY-D0205AS1	Carbocisteine-13C3-1		/	否
HY-N0001S2	(-)-Epicatechin-13C3		/	否
HY-N0092S4	Inosine-13C3	Agonist	/	否
HY-N0230S5	β-Alanine-13C		/	否
HY-N0368S1	Linalool-13C3		/	否
HY-N0803S1	Myrcene-13C3	Inhibitor	/	否
HY-N1071	Wilforol C		/	否
HY-N12816	Glaucogenin C 3-O-α-L-cymaropyranosyl-(1→4)–β-D-digitoxopyranosyl-(1→4)-β-D-canaropyranoside		/	否
HY-N14052	Arizonin C3	Inhibitor	/	否
HY-N14105	Cinatrin C3	Inhibitor	/	否
HY-N14419	Salfredin C3	Inhibitor	/	否
HY-N14460	Pluracidomycin C3	Inhibitor	/	否
HY-N14691	Platenomycin C3	Inhibitor	/	否
HY-N1849	3'-Methoxyrocaglamide		/	否
HY-N2355	Solasurine		/	否
HY-N5181	Parvodicin C3	Inhibitor	/	否
HY-N7091S1	Atrazine-13C3,15N3		/	否
HY-N7092S22	D-Fructose-13C3		/	否
HY-N7092S23	D-Fructose-13C3-1		/	否
HY-N9522	β-D-glucopyranosyl-[α-L-rhamnopyranosyl-(1→3)-βD-glucuronopyranosyl-(1→3)]-3β-hydroxyolean-12-ene28-oate		99.95%	否
HY-P6696S	β-CL, Ala(13C3,15N) TFA		/	否
HY-R04628	mmu-miR-200c-3p mimic		/	否
HY-RI04615	mmu-miR-200c-3p inhibitor		/	否
HY-RI04616	hsa-miR-29c-3p inhibitor		/	否
HY-RS16401	NT5C3A Human Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS16520	C3 Mouse Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS22951	C3 Rat Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS23044	Akr1c3 Rat Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS27683	Nt5c3a Rat Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-RS28019	C3ar1 Rat Pre-designed siRNA Set A	Pre-designed Set	/	否
HY-W007941S	Fmoc-Ser(tBu)-OH-13C3,15N		/	否
HY-W009204S5	Fmoc-Ala-OH-13C3	Modulator	98.5%	否
HY-W012578S1	2-Isopropyl-3-methoxypyrazine-13C3		/	否
HY-W012932S	2,4-Dimethylthiazole-13C3		/	否
HY-W013061S11	Tripalmitin (Glycerol 13C3,13C 99%)		/	否
HY-W020044S	DL-alpha-Tocopherol-13C3	Inhibitor	/	否
HY-W021040S	Fludioxonil-13C3		/	否
HY-W046063	O-Phthalimide-C3-acid		/	否
HY-W091039S	N-Acetyl-α-neuraminic acid-13C3		/	否
HY-W1110947	(S)-3-Phosphoglyceric acid-13C3 sodium		/	否
HY-W1113139	H2N-PEG4-C3-OH		/	否
HY-W128657S	3-Chloro-2-hydroxypropanoic acid-13C3		/	否
HY-W130878	4-Octylphenol	Activator	/	否
HY-W145482S1	3-O-Methyl-D-glucopyranose-13C6		/	否
HY-W152813S	3',4'-Dichloro-4-biphenylol-13C12		/	否
HY-W156840S	OTNE-13C3		/	否
HY-W190925	APN-C3-biotin		/	否
HY-W336094	1,3-Glyceryl dilinoleate		/	否
HY-W352408	1,2,3-Tri-α-linolenoyl glycerol		/	否
HY-W585819S	3-Chloropropane-1,2-diol dipalmitate-13C3		/	否
HY-W590573	C3 Ceramide		/	否
HY-W653853	Ritonavir-13C3		/	否
HY-W654120	Creatine-13C3		/	否
HY-W654126	Cytarabine-13C3		/	否
HY-W654127	Cytarabine-13C3 5'-monophosphate		/	否
HY-W654156	Diclazuril-13C3,15N2	Inhibitor	/	否
HY-W654362	(R)-2-Thioxothiazolidine-4-carboxylic acid-13C3		/	否
HY-W686763	Triacetylphloroglucinol		/	否
HY-W743781	N-Nitrosonornicotine-d4		/	否
HY-W747639	Glycidyl Stearate-13C3		/	否
HY-W748200	3-Hydroxypropionic acid-13C3 sodium		/	否
HY-W748290	3,4,4',5-Tetrachloro-1,1'-biphenyl-13C12		/	否
HY-W749756	rac-1,2-Distearoyl-3-chloropropanediol-13C3		/	否
HY-W750674	Indole-3-carboxaldehyde-13C8		/	否
HY-W751098	Aldosterone-13C3		/	否
HY-W751099	Corticosterone-13C3		/	否
HY-W767866	N-Acetyl-S-(2-carboxyethyl)cysteine-13C3 dicyclohexylamine		/	否
HY-W769017	Thiothiamine-13C3		/	否
HY-W769714	Favipiravir-13C3	Inhibitor	/	否
HY-W770183	Uric acid-13C3		/	否
HY-W777148	Anagrelide-13C3		/	否
HY-W778140	Diethyl phosphate-13C4 sodium	Inhibitor	/	否
HY-W778183	3,5,6-Trichloro-2-pyridinol-13C5		/	否
HY-W778812	Acrylamide-13C3		/	否
HY-W779345	Reverse T3-13C6		/	否
HY-109506S10	DPPC-13C3		/	否
HY-W018171S2	3,5,6-Trichloro-2-pyridinol-13C3		/	否
HY-111843	Ch55-O-C3-NH2		/	否